Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma

PURPOSE: Proton magnetic resonance spectroscopy (MRS) of the brain can detect 2-hydroxyglutarate (2HG), the oncometabolite produced in neoplasms harboring a mutation in the gene coding for isocitrate dehydrogenase (IDH). We conducted a prospective longitudinal imaging study to determine whether quan...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Choi, Changho, Raisanen, Jack M., Ganji, Sandeep K., Zhang, Song, McNeil, Sarah S., An, Zhongxu, Madan, Akshay, Hatanpaa, Kimmo J., Vemireddy, Vamsidhara, Sheppard, Christie A., Oliver, Dwight, Hulsey, Keith M., Tiwari, Vivek, Mashimo, Tomoyuki, Battiste, James, Barnett, Samuel, Madden, Christopher J., Patel, Toral R., Pan, Edward, Malloy, Craig R., Mickey, Bruce E., Bachoo, Robert M., Maher, Elizabeth A.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2016
Matèries:
Original Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5477829/
https://ncbi.nlm.nih.gov/pubmed/28248126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.67.1222
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars